Publicaciones en colaboración con investigadores/as de University of Paris-Sorbonne (76)

2024

  1. Erratum: Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome medicine (2023) 15 1 (22))

    Genome medicine

  2. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

    Human Genetics and Genomics Advances, Vol. 5, Núm. 3

  3. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells

    Science Immunology, Vol. 9, Núm. 91

  4. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

    The Lancet Rheumatology, Vol. 6, Núm. 6, pp. e374-e383

2023

  1. 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 6, pp. 754-762

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

    RMD Open, Vol. 9, Núm. 1

  4. Core-genome multilocus sequence typing and core-SNP analysis of Clostridium neonatale strains isolated in different spatio-temporal settings

    Microbiology Spectrum, Vol. 11, Núm. 6

  5. Digestion and gut-microbiota fermentation of cocoa melanoidins: An in vitro study

    Journal of Functional Foods, Vol. 109

  6. Exploring the Association between Citrus Nutraceutical Eriocitrin and Metformin for Improving Pre-Diabetes in a Dynamic Microbiome Model

    Pharmaceuticals, Vol. 16, Núm. 5

  7. Exploring the Potential of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 as Promising Psychobiotics Using SHIME

    Nutrients, Vol. 15, Núm. 6

  8. Impact of Lactobacillus acidophilus—La5 on Composition and Metabolism of the Intestinal Microbiota of Type 2 Diabetics (T2D) and Healthy Individuals Using a Microbiome Model

    Fermentation, Vol. 9, Núm. 8

  9. Infant formula with 2′-FL + LNnT positively modulates the infant gut microbiome: An in vitro study using human intestinal microbial ecosystem model

    International Dairy Journal, Vol. 139

  10. Maternal Diet May Modulate Breast Milk Microbiota—A Case Study in a Group of Colombian Women

    Microorganisms, Vol. 11, Núm. 7

  11. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

  12. Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)

    Gut, Vol. 72, Núm. 8, pp. 1581-1591

  13. Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

    RMD Open, Vol. 9, Núm. 1

2022

  1. 2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19

    Annals of the rheumatic diseases, Vol. 81, Núm. 1, pp. 34-40

  2. Bacterial inoculant-assisted phytoremediation affects trace element uptake and metabolite content in Salix atrocinerea

    Science of the Total Environment, Vol. 820

  3. Core-, pan- and accessory genome analyses of Clostridium neonatale: Insights into genetic diversity

    Microbial Genomics, Vol. 8, Núm. 5